Abstract
Precisely diagnosing metabolic dysfunction-associated fatty liver disease (MAFLD) and its severity degree can effectively delay disease progression and have important guiding values for treatment. In recent years, research on non-invasive diagnosis of metabolic dysfunction-associated fatty liver disease has made great progress, suggesting that we should not only give full play advantage to professional personnel in the field of liver disease but also actively cooperate with personnel in other fields to explore different high-performance non-invasive diagnostic methods to achieve early detection, diagnosis, and treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
